Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
22 active Medicare policies list M35.09, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
7 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M35.09 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
| Hematopoietic Cell Transplantation for Autoimmune Diseases and Miscellaneous Indications | Aug 31, 2023 | Covered |
| Optic Nerve and Retinal Imaging Methods | May 17, 2023 | Covered |
| Salivary Tests | Aug 31, 2023 | Covered |
| Xerostomia: Selected Treatments | May 8, 2023 | Covered |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J5 · Effective Nov 27, 2025
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2025
J9 · Effective Oct 1, 2024
| Policy | Effective | Status of M35.09 |
|---|
| Medically Necessary Optical Hardware | Not recorded | Covered |
|---|
| Policy | Effective | Status of M35.09 |
|---|---|---|
| Gamma Glutamyl Transferase Testing | Jul 1, 2026 | Covered |